15.21
price up icon0.66%   0.10
after-market Dopo l'orario di chiusura: 15.19 -0.02 -0.13%
loading

Mineralys Therapeutics Inc Azioni (MLYS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
5.17%
46.75
44.45 60.11 45.17 35.36
Operating Income/Loss
5.17%
-46.75
-44.45 -60.11 -45.17 -35.36
Nonoperating Income/Loss
55.28%
3.472
2.236 3.764 4.154 3.854
Income/Loss From Continuing Operations Before Tax
2.52%
-43.27
-42.21 -56.34 -41.01 -31.51
Income/Loss From Continuing Operations After Tax
2.52%
-43.27
-42.21 -56.34 -41.01 -31.51
Net Income/Loss
2.52%
-43.27
-42.21 -56.34 -41.01 -31.51
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
23.11%
65.45
53.16 49.82 49.36 44.90
Diluted Average Shares
23.11%
65.45
53.16 49.82 49.36 44.90
Basic Earnings Per Share
16.46%
-0.66
-0.79 -1.13 -0.83 -0.70
Diluted Earnings Per Share
16.46%
-0.66
-0.79 -1.13 -0.83 -0.70
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Capitalizzazione:     |  Volume (24 ore):